Table 3

Change in BPI severity score associated with each increment of EQ-5D-5L

Incremental increase in response to EQ-5D-5L pain and discomfort questionAssociated change in median response to BPI pain severity scoreAdjusted p value
Baseline intervention
 Increment 1–22 (1.75–2.88)0.06
 Increment 2–32.38 (1.25–3.13)<0.01
 Increment 3–41.75 (1.00–2.75)0.01
 Increment 4–51.63 (0.88–2.25)0.1
Intervention 3 months
 Increment 1–22 (1.38–3.00)0.01
 Increment 2–32.5 (1.25–3.63)0.01
 Increment 3–41.88 (0.50–3.25)0.04
 Increment 4–52.25 (0.75–3.86)0.19
Intervention 12 months
 Increment 1–22.75 (1.25–3.75)0.01
 Increment 2–31.63 (0.25–2.75)0.14
 Increment 3–42 (0.75–3.50)0.07
 Increment 4–52.13 (−2.75 to 3.63)0.66
Usual care cohort 12 months
 Increment 1–21.25 (0.25–1.88)0.49
 Increment 2–33.00 (2.13–4.00)<0.01
 Increment 3–43.25 (1.88–4.25)0.02
 Increment 4–5−0.50 (−2.50 to 0.88)0.71
  • Change in median BPI responses associated with incremental change in EQ-5D-5L response with pairwise comparisons. Statistically significant changes in median responses are highlighted in bold to demonstrate the discriminatory power of the EQ-5D-5L in detecting differences in pain severity.

  • BPI, Brief Pain Inventory; EQ-5D-5L, EuroQol 5 Dimension 5 Level.